Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramOfficers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.
Kurtz George0B / 217S · 10 late217 trades$54.77M| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 6 | Wassil JimEVP, Chief Scientific Ofc, COO |  PCVXVaxcyte, Inc.Open-market sale · 10b5-1 plan | SELL | $21K 343 sh | Nov 4, 2026 |
| 6 | Felice Laura L.EVP, Chief Financial Officer |  BJBJ's Wholesale Club Holdings, Inc.Option exercise · 10b5-1 plan | M | $170K 10.0K sh | Nov 4, 2026 traded Nov 2, 2026 |
| 6 | Kurtz GeorgeDirector, PRESIDENT AND CEO | CRWDCrowdStrike Holdings, Inc. Open-market sale · 10b5-1 plan | SELL | $242K 1,000 sh | Nov 4, 2026 traded Nov 3, 2026 |
| 6 | Reardon AndrewCLO & Secretary | LGNDLIGAND PHARMACEUTICALS INC Open-market sale · 10b5-1 plan | SELL | $87K 283 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 5 | Benton Kelly WVP & CAO |  SAIASAIA INCTax withholding | F | $46K 129 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 5 | Winitzer OriDirector |  LCIDLucid Group, Inc.Open-market sale · 10b5-1 plan | SELL | $3,090 1,000 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 5 | Baszucki GregoryDirector |  RBLXRoblox CorpOpen-market sale · 10b5-1 plan | SELL | $35K 800 sh | Nov 4, 2026 traded Nov 3, 2026 |
| 5 | Marinaro MichaelPresident |  MDTMedtronic plcGrant or award | A | — 43.0K sh | Nov 4, 2026 traded Nov 2, 2026 |
| 5 | de Verneuil VaninaEVP, General Counsel, Corp Sec |  VIRVir Biotechnology, Inc.Open-market sale · 10b5-1 plan | SELL | $15K 1,343 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 5 | Comly Barbara J.EVP, GC & Corporate Secretary | MIAXMIAMI INTERNATIONAL HOLDINGS, INC. Option exercise · 10b5-1 plan | M | $567K 47.2K sh | Nov 4, 2026 traded Nov 4, 2026 |
| 5 | Marinaro MichaelPresident | MDTMedtronic plc Grant or award | A | — 16.4K sh | Nov 4, 2026 traded Nov 2, 2026 |
| 5 | Baszucki GregoryDirector | RBLXRoblox Corp Open-market sale · 10b5-1 plan | SELL | $35K 800 sh | Nov 4, 2026 traded Nov 3, 2026 |
| 5 | Clark Benjamin M.EVP - Global Supply Chain |  ECLECOLAB INC.Option exercise | M | — 8,843 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 4 | Borgeson BlakeDirector |  RXRXRECURSION PHARMACEUTICALS, INC.Open-market sale · 10b5-1 plan | SELL | $155K 40.0K sh | Nov 4, 2026 traded Nov 3, 2026 |
| 4 | Tsao DavidDirector, Chief Technology Officer | BLLNBillionToOne, Inc. Option exercise · 10b5-1 plan | M | $28K 10.0K sh | Nov 4, 2026 traded Nov 2, 2026 |
| 4 | Tsao DavidDirector, Chief Technology Officer | BLLNBillionToOne, Inc. Option exercise · 10b5-1 plan | M | $28K 10.0K sh | Nov 4, 2026 traded Nov 2, 2026 |
| 4 | Atay OguzhanDirector, Chairman and CEO | BLLNBillionToOne, Inc. Option exercise · 10b5-1 plan | M | $23K 8,334 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 3 | Tang StanleyDirector | DASHDoorDash, Inc. Open-market sale · 10b5-1 plan | SELL | $18K 100 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 3 | Cowan ElviaSVP, Finance & CAO | PCVXVaxcyte, Inc. Open-market sale · 10b5-1 plan | SELL | $36K 586 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 3 | Reardon AndrewCLO & Secretary | LGNDLIGAND PHARMACEUTICALS INC Open-market sale · 10b5-1 plan | SELL | $39K 120 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 3 | Tang StanleyDirector | DASHDoorDash, Inc. Open-market sale · 10b5-1 plan | SELL | $36K 200 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 3 | Nithrakashyap ArvindDirector, Chief Technology Officer | RBRKRubrik, Inc. Open-market sale · 10b5-1 plan | SELL | $39K 341 sh | Nov 4, 2026 traded Nov 4, 2026 |
| 3 | Merriman Dwight ADirector |  MDBMongoDB, Inc.Open-market sale · 10b5-1 plan | SELL | $29K 83 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 3 | Nithrakashyap ArvindDirector, Chief Technology Officer | RBRKRubrik, Inc. Open-market sale · 10b5-1 plan | SELL | $47K 389 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 3 | Merriman Dwight ADirector | MDBMongoDB, Inc. Open-market sale · 10b5-1 plan | SELL | $42K 120 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 3 | Reardon AndrewCLO & Secretary | LGNDLIGAND PHARMACEUTICALS INC Open-market sale · 10b5-1 plan | SELL | $25K 80 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 3 | Tsuchimoto Kim RDirector |  MNPRMonopar TherapeuticsOption exercise · 10b5-1 plan | M | — 856 sh | Nov 4, 2026 traded Nov 4, 2026 |
| 3 | Tang StanleyDirector | DASHDoorDash, Inc. Open-market sale · 10b5-1 plan | SELL | $38K 200 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 3 | Nithrakashyap ArvindDirector, Chief Technology Officer | RBRKRubrik, Inc. Open-market sale · 10b5-1 plan | SELL | $24K 198 sh | Nov 4, 2026 traded Nov 4, 2026 |
| 3 | Nithrakashyap ArvindDirector, Chief Technology Officer | RBRKRubrik, Inc. Open-market sale · 10b5-1 plan | SELL | $25K 219 sh | Nov 4, 2026 traded Nov 3, 2026 |
| 3 | Nithrakashyap ArvindDirector, Chief Technology Officer | RBRKRubrik, Inc. Open-market sale · 10b5-1 plan | SELL | $11K 87 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 3 | Kurtz GeorgeDirector, PRESIDENT AND CEO | CRWDCrowdStrike Holdings, Inc. Open-market sale · 10b5-1 plan | SELL | $42K 165 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 3 | Tang StanleyDirector | DASHDoorDash, Inc. Open-market sale · 10b5-1 plan | SELL | $18K 100 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 3 | Nithrakashyap ArvindDirector, Chief Technology Officer | RBRKRubrik, Inc. Open-market sale · 10b5-1 plan | SELL | $47K 397 sh | Nov 4, 2026 traded Nov 3, 2026 |
| 3 | Matsuda MasaruEVP, Chief Legal Officer |  ARQTArcutis Biotherapeutics, Inc.Option exercise · 10b5-1 plan | M | $146K 40.0K sh | Nov 4, 2026 traded Nov 4, 2026 |
| 3 | Ring ChristineChief Legal Officer |  NRIXNurix Therapeutics, Inc.Option exercise · 10b5-1 plan | M | $50K 5,786 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 3 | Fukushima RyanCEO, Data |  TEMTempus AI, Inc.Open-market sale · 10b5-1 plan | SELL | $5,943 80 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 3 | Felice Laura L.EVP, Chief Financial Officer | BJBJ's Wholesale Club Holdings, Inc. Option exercise · 10b5-1 plan | M | — 10.0K sh | Nov 4, 2026 traded Nov 2, 2026 |
| 2 | Ghaffarian Kamal SeyedDirector, 10% Owner |  XEX-Energy, Inc.Other acquisition or disposition · 10b5-1 plan | J | — 108.2K sh | Nov 4, 2026 traded Nov 2, 2026 |
| 2 | Reardon AndrewCLO & Secretary | LGNDLIGAND PHARMACEUTICALS INC Option exercise · 10b5-1 plan | M | $261K 5,000 sh | Nov 4, 2026 traded Nov 2, 2026 |
DRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
MTDRMatador Resources CoNov 5 – Nov 98 insiders$625K
FERGFerguson Enterprises Inc. /DE/Oct 12 – Oct 167 insiders$7.38M
SYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
UPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M
IBEXIBEX LtdSep 14 – Sep 166 insiders$2.01M
ARQQArqit Quantum Inc.Oct 2 – Oct 136 insiders$369K
BBTBeacon Financial CorpOct 26 – Oct 306 insiders$274K